Showing 1721-1730 of 3868 results for "".
The Dermatology Market: A Tidal Wave of Private Equity Investment
https://practicaldermatology.com/topics/practice-management/the-dermatology-market-a-tidal-wave-of-private-equity-investment/20416/A beginner's guide to the complex world of mergers and acquisitions.Botox in the Masseter
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/botox-in-the-masseter/20463/Cosmetic and medical benefits of high-dose injection into the masseter muscle.Isotretinoin Insights: Patient Counseling
https://practicaldermatology.com/topics/practice-management/isotretinoin-insights-patient-counseling/21179/A panel of acne specialists discusses their approach to prescribing isotretinoin, in follow-up to last month's overview of isotretinoin in practice.Advancing Digital Medicine in Dermatology
https://practicaldermatology.com/programs/practical-dermatology/advancing-digital-medicine-in-dermatology/18187/The Digital Medicine Society (DiME) is a global nonprofit dedicated to advancing the ethical, effective, equitable, and safe use of digital medicine to redefine health care and improve lives. DiME recently released a new set of resources, available at www.dimesociety.org/access-resources/, to advancHighlighting the Role of the NP and PA: Insights from the Dermatology Education Foundation
https://practicaldermatology.com/topics/practice-management/highlighting-the-role-of-the-np-and-pa-insights-from-the-dermatology-education-foundation/20806/NPs and PAs ease the burden of an overwhelming demand for dermatologic care.DermWireTV: Atopic Dermatitis Pipeline Watch, a Potential New Skin Cancer Treatment; Demystifying Itch, and the Premiere of PA Perspectives
https://practicaldermatology.com/topics/practice-management/dermwiretv-atopic-dermatitis-pipeline-watch-a-potential-new-skin-cancer-treatment-demystifying-itch-and-the-premiere-of-pa-perspectives/20228/Escient Pharmaceuticals, Rapt Therapeutics, and Connect Biopharma each report positive results from early clinical studies in AD. Finnish researchers discover a potential treatment for cutaneous squamous cell carcinoma in an existing chemotherapy drug. Research out of Harvard Medical School links ecDispatches from the 2022 Skin of Color Update
https://practicaldermatology.com/conferences/skin-of-color-update-2022/dispatches-from-the-2022-skin-of-color-update/23822/Co-chair Dr. Andrew F. Alexis shares highlights from the recent meeting.DermWireTV: Diversity in Dermatology; Inclusive Beauty Initiatives; Eczema Awareness Month
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diversity-in-dermatology-inclusive-beauty-initiatives-eczema-awareness-month/20152/La Roche-Posay and the Women's Dermatologic Society have partnered to sponsor a Fellowship in the Department of Dermatology at Howard University's College of Medicine for Underrepresented in medicine medical students. WDS President Mona Gohara, MD shares insights about the need to support DEI in derTaylor Made: Procedure Helps Fade Stubborn Facial Acne Scars
https://practicaldermatology.com/topics/acne-rosacea/taylor-made-procedure-helps-fade-stubborn-facial-acne-scars/23519/CSF faculty member Mark Taylor, MD describes how he treats facial acne scars.Skin Cancer Perceptions, Cimzia for Psoriasis, Eczema and CV Risk
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-skin-cancer-perceptions-cimzia-for-psoriasis-eczema-and-cv-risk/18301/A new national survey, Skin Cancer In America 2018, conducted by Health Union, explores perceptions of patients with skin cancer. Cimzia (certolizumab pegol, UCB) has received FDA approval for treatment of adults with moderate to severe plaque psoriasis. Cimzia is the first Fc-free, PEGylated anti T